Company

As CEO and Founder of Trialogics, Chris brings a wealth of technical expertise and clinical knowledge to the team. He understands that technology is a tool to assist sponsors with their clinical trials and different trials require different technology to succeed. He founded Trialogics to solve the problem of outdated, inflexible clinical software. He guides Trialogics in developing software that is right for specific clinical trial needs.

John Moore has been Executive Chairman of Trialogics since inception. He has invested in energy, new materials, medical devices and biotech. In 2002, he co-founded Edson Moore Healthcare Ventures to acquire sixteen interests in biotech companies from Elan Pharmaceuticals for $148 million. He served as Chairman of ImaRx Therapeutics and Elite Pharmaceuticals as well as holding numerous other biotech company board positions. He believes the best new business idea is to solve the biggest headache of his last business. He is excited by Trialogics mission to help deliver faster cures through better systems.

Edoardo Bugnone has extensive experience in private equity. Prior to setting up Top Quartile Partners, he was a Founding Partner of Geneva-based Argos Soditic. Argos Soditic is a private equity firm that was established in 1989 to invest in small- and mid-sized buyouts in France, Italy and Switzerland and currently manages more than €500m. Throughout his tenure at the firm, aside from his direct investments in Switzerland, Italy, France and Portugal, Mr. Bugnone was responsible for Investor Relations and Group Strategy. Between 2001 and 2002, Mr. Bugnone was Chairman of the European Private Equity and Venture Capital Association (EVCA).